|
WO2016126773A1
|
|
Self-assembled organosilane coatings for resorbable metal medical devices
|
|
WO2016118852A1
|
|
Use of eomesodermin to determine risk of allograft rejection
|
|
WO2016118546A1
|
|
Furniture-integrated monitoring system and load cell for same
|
|
WO2016115133A1
|
|
Polymer microbubbles as x-ray dark field contrast agents
|
|
WO2016085946A1
|
|
Active cxcr4+ immune cells and methods for their production and use
|
|
US2016076827A1
|
|
Variable thermal insulation
|
|
WO2016077724A1
|
|
(2-amino-4(arylamino)phenyl) carbamates
|
|
WO2016073933A1
|
|
Magnesium-based suture anchor devices
|
|
US2016129155A1
|
|
Musculoskeletal tissue fabrication
|
|
WO2016077118A1
|
|
Stem cell-based technologies for avian skeletal tissue engineering and regeneration
|
|
WO2016073298A1
|
|
Parp genomic variants conferring resistance and sensitization to chemotherapy under inhibition
|
|
WO2016033312A1
|
|
Magnesium enhanced/induced bone formation
|
|
WO2016028990A1
|
|
System and method for monitoring a reactor system using optical fiber based sensors
|
|
US2016082115A1
|
|
Reverse thermal gels and uses therefor
|
|
US2016058794A1
|
|
Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
|
|
US2015306183A1
|
|
Five-coordinate neuroglobin and use thereof as a blood substitute
|
|
US2015366913A1
|
|
Biologic Scaffold For Prevention of Pulmonary Fibrosis
|
|
WO2015195951A1
|
|
Combination therapy to enhance the anticancer efficacy of platinum drugs
|
|
WO2015164452A1
|
|
Method and system for monitoring glucose transport and metabolism by spin-lock magnetic resonance
|
|
WO2015164443A1
|
|
Method and system for monitoring a tissue parameter such as proteoglycan content by magnetic resonance imaging
|
